Recomienda este artículo a tus amigos:
Combination Studies with the Vascular Disrupting Agent Ca4p: Clinical Studies Combined with Chemotherapy and Radioimmunotherapy, and Dce-mri and Immunohistochemistry Correlation Andrew Gaya
Nuestros clientes opinan:
Combination Studies with the Vascular Disrupting Agent Ca4p: Clinical Studies Combined with Chemotherapy and Radioimmunotherapy, and Dce-mri and Immunohistochemistry Correlation
Andrew Gaya
This work represents studies carried out at Mount Vernon Hospital and UCL, and sponsored by Cancer Research UK, between 2003 and 2006. Phase I/II Clinical trial studies of the vascular disrupting agent Combretastatin A4 Phosphate (CA4P) are presented - in combination with cytotoxic chemotherapy (Paclitaxel and Carboplatin), and radioimmunotherapy. Dynamic Contrast Enhanced MRI data from the studies is presented and discussed, and a supporting immunohistochemistry correlation study of vascular markers is also presented.
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 10 de mayo de 2011 |
| ISBN13 | 9783838343532 |
| Editores | LAP LAMBERT Academic Publishing |
| Páginas | 256 |
| Dimensiones | 150 × 15 × 226 mm · 399 g |
| Lengua | Alemán |
Ver todo de Andrew Gaya ( Ej. Paperback Book )